Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

The Pathogenic Neisseria Use a Streamlined Set of Peptidoglycan Degradation Proteins for Peptidoglycan Remodeling, Recycling, and Toxic Fragment Release.

Schaub RE, Dillard JP.

Front Microbiol. 2019 Jan 31;10:73. doi: 10.3389/fmicb.2019.00073. eCollection 2019. Review.

2.

Neisseria gonorrhoeae PBP3 and PBP4 Facilitate NOD1 Agonist Peptidoglycan Fragment Release and Survival in Stationary Phase.

Schaub RE, Perez-Medina KM, Hackett KT, Garcia DL, Dillard JP.

Infect Immun. 2019 Jan 24;87(2). pii: e00833-18. doi: 10.1128/IAI.00833-18. Print 2019 Feb.

PMID:
30510100
3.

The low-molecular-mass, penicillin-binding proteins DacB and DacC combine to modify peptidoglycan cross-linking and allow stable Type IV pilus expression in Neisseria gonorrhoeae.

Obergfell KP, Schaub RE, Priniski LL, Dillard JP, Seifert HS.

Mol Microbiol. 2018 Mar 24. doi: 10.1111/mmi.13955. [Epub ahead of print]

PMID:
29573486
4.

Digestion of Peptidoglycan and Analysis of Soluble Fragments.

Schaub RE, Dillard JP.

Bio Protoc. 2017 Aug 5;7(15). pii: e2438. doi: 10.21769/BioProtoc.2438.

5.

Two lytic transglycosylases in Neisseria gonorrhoeae impart resistance to killing by lysozyme and human neutrophils.

Ragland SA, Schaub RE, Hackett KT, Dillard JP, Criss AK.

Cell Microbiol. 2017 Mar;19(3). doi: 10.1111/cmi.12662. Epub 2016 Nov 3.

6.

Lytic transglycosylases LtgA and LtgD perform distinct roles in remodeling, recycling and releasing peptidoglycan in Neisseria gonorrhoeae.

Schaub RE, Chan YA, Lee M, Hesek D, Mobashery S, Dillard JP.

Mol Microbiol. 2016 Dec;102(5):865-881. doi: 10.1111/mmi.13496. Epub 2016 Sep 26.

7.

Analysis of Peptidoglycan Fragment Release.

Schaub RE, Lenz JD, Dillard JP.

Methods Mol Biol. 2016;1440:185-200. doi: 10.1007/978-1-4939-3676-2_14.

8.

Proteobacterial ArfA peptides are synthesized from non-stop messenger RNAs.

Schaub RE, Poole SJ, Garza-Sánchez F, Benbow S, Hayes CS.

J Biol Chem. 2012 Aug 24;287(35):29765-75. doi: 10.1074/jbc.M112.374074. Epub 2012 Jul 12.

9.

tmRNA regulates synthesis of the ArfA ribosome rescue factor.

Garza-Sánchez F, Schaub RE, Janssen BD, Hayes CS.

Mol Microbiol. 2011 Jun;80(5):1204-19. doi: 10.1111/j.1365-2958.2011.07638.x. Epub 2011 Mar 30.

10.

Deletion of the RluD pseudouridine synthase promotes SsrA peptide tagging of ribosomal protein S7.

Schaub RE, Hayes CS.

Mol Microbiol. 2011 Jan;79(2):331-41. doi: 10.1111/j.1365-2958.2010.07467.x. Epub 2010 Nov 29.

11.

Analogues of platelet activating factor. 8. Antagonists of PAF containing an aromatic ring linked to a pyridinium ring.

Trova MP, Wissner A, Carroll ML, Kerwar SS, Pickett WC, Schaub RE, Torley LW, Kohler CA.

J Med Chem. 1993 Mar 5;36(5):580-90.

PMID:
8496938
12.

Analogues of platelet activating factor. 7. Bis-aryl amide and bis-aryl urea receptor antagonists of PAF.

Wissner A, Carroll ML, Johnson BD, Kerwar SS, Pickett WC, Schaub RE, Torley LW, Trova MP, Kohler CA.

J Med Chem. 1992 Dec 25;35(26):4779-89.

PMID:
1336052
13.

Studies of the effect of a platelet-activating factor antagonist, CL 184,005, in animal models of gram-negative bacterial sepsis.

Torley LW, Pickett WC, Carroll ML, Kohler CA, Schaub RE, Wissner A, DeJoy SQ, Oronsky AL, Kerwar SS.

Antimicrob Agents Chemother. 1992 Sep;36(9):1971-7.

14.

Analogues of platelet activating factor. 6. Mono- and bis-aryl phosphate antagonists of platelet activating factor.

Wissner A, Carroll ML, Green KE, Kerwar SS, Pickett WC, Schaub RE, Torley LW, Wrenn S, Kohler CA.

J Med Chem. 1992 May 1;35(9):1650-62.

PMID:
1578493
15.

Analogues of platelet activating factor. 4. Some modifications of the phosphocholine moiety.

Wissner A, Schaub RE, Sum PE, Kohler CA, Goldstein BM.

J Med Chem. 1986 Mar;29(3):328-33.

PMID:
3950913
16.

Analogues of platelet activating factor (PAF). 2. Some modifications of the glycerine backbone.

Wissner A, Schaub RE, Sum PE, Kohler CA, Goldstein BM.

J Med Chem. 1985 Sep;28(9):1181-7.

PMID:
4032422
17.

Analogues of platelet activating factor (PAF). 1. Some modifications of the alkoxy chain.

Wissner A, Sum PE, Schaub RE, Kohler CA, Goldstein BM.

J Med Chem. 1984 Sep;27(9):1174-81.

PMID:
6471071
18.

Prostaglandins and congeners. 22. Synthesis of 11-substituted derivatives of 11-deoxyprostaglandins E1 and E2. Potential bronchodilators.

Floyd MB, Schaub RE, Siuta GJ, Skotnicki JS, Grudzinskas CV, Weiss MJ, Dessy F, VanHumbeeck L.

J Med Chem. 1980 Aug;23(8):903-13.

PMID:
7401116
19.

Prostaglandins and congeners. 16. Synthesis and bronchodilator activity of dl-11-doexy-3-thiaprostaglandins.

Skotnicki JS, Schaub RE, Weiss MJ, Dessy F.

J Med Chem. 1977 Dec;20(12):1662-5.

PMID:
592330
20.

Prostaglandins and congeners. 15. Synthesis and bronchodilator activity of dl-11-deoxy-15- or 16-alkylprostaglandins.

Skotnicki JS, Schaub RE, Bernady KF, Siuta GJ, Poletto JF, Weiss MJ.

J Med Chem. 1977 Dec;20(12):1551-7.

PMID:
592319
21.
23.

Synthesis of 7-dimethylamino-6-demethyl-6-deoxytetracycline (minocycline) via 9-nitro-6-demethyl-6-deoxytetracycline.

Church RF, Schaub RE, Weiss MJ.

J Org Chem. 1971 Mar 12;36(5):723-5. No abstract available.

PMID:
5545572
24.

The synthesis of certain 17-alpha-alkyl corticoids.

Schaub RE, Weiss MJ.

J Med Chem. 1967 Sep;10(5):789-95. No abstract available.

PMID:
6057831
26.

THE ORAL PROGESTATIONAL ACTIVITY OF THE 3-KETALS OF CERTAIN 17-ACETOXY- AND 17-ALKYLPROGESTERONES.

WEISS MJ, POLETTO JF, ALLEN GR Jr, SCHAUB RE, RINGLER I.

J Med Chem. 1964 Nov;7:804-6. No abstract available.

PMID:
14262817
27.

Effects of conditioned stimulus intensity on the conditioned emotional response.

KAMIN LJ, SCHAUB RE.

J Comp Physiol Psychol. 1963 Jun;56:502-7. No abstract available.

PMID:
13962090
28.

THE BIOLOGICAL ACTIVITY OF CERTAIN 17 ALPHA,20;20,21- BISMETHYLENEDIOXY CORTICOID DERIVATIVES.

WEISS MJ, SCHAUB RE, MAUER S.

J Med Pharm Chem. 1962 Jul;91:858-61. No abstract available.

PMID:
14056418

Supplemental Content

Loading ...
Support Center